Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11866445 Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jens Larsen0

Date of Patent

January 9, 2024

0

Patent Application Number

176635570

Date Filed

May 16, 2022

0

Patent Citations

US Patent 11365204 Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

0

US Patent 11384096 Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

0

US Patent 7511045 Compounds for the treatment of inflammatory diseases

0

US Patent 8114878 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases

0

US Patent 8486948 Piperazinodihydrothienopyrimidine derivatives

0

US Patent 8637519 Heterocycle-substituted piperazino-dihydrothienopyrimidines

0

US Patent 8754073 Substituted piperazino-dihydrothienopyrimidines

0

US Patent 9161927 Drug combinations containing PDE4 inhibitors and NSAIDs

0

...

Patent Primary Examiner

0

CPC Code

0

0

Patent abstract

The present invention relates to novel substituted dihydrothienopyrimidines with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11866445 Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.